About this trial
The aim of researchers is to compare the effects of three different local anesthetic concentrations and volumes on opioid consumption, postoperative analgesic efficacy, and pain scores during ultrasound-guided SPSIP blocks in patients undergoing modified radical mastectomy. Additionally, we aim to map and identify the dermatomal areas where different concentrations and volumes of SPSIP blocks provide analgesia.
Eligibility criteria
Qualifiers
The study included adult patients over 18 years of age who underwent modified radical mastectomy under general anesthesia and were classified in risk groups I-II-III according to the American Society of Anesthesiologists (ASA) risk classification.
Disqualifiers
patients with coagulopathy,
patients with signs of infection at the block application site,
patients with ASA IV
patients with known allergies to any of the study drugs,
Trial design
Treatments tested in this trial
- Serratus Posterior Superior Intercostal Plane (SPSIP) block 40 ml of 0.125% bupivacaine
- Serratus Posterior Superior Intercostal Plane (SPSIP) 50 ml of 0.125% bupivacaine
- Serratus Posterior Superior Intercostal Plane (SPSIP) 30 ml of 0.25% bupivacaine